Credit Suisserates CCL asUpgrade to Outperform from Neutral(1) -
Rating is upgraded to Outperform from Neutral and the target is raised to $11.25 from $9.00.
- Forums
- ASX - By Stock
- CCL
- Ann: 2020 Half Year Result Investor Presentation Pack
Ann: 2020 Half Year Result Investor Presentation Pack, page-9
Featured News
Add CCL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.30 |
Change
0.000(0.00%) |
Mkt cap ! $9.629B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CCL (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online